BioCentury | Feb 15, 2010
Company News

Ikonisys sales and marketing update

...chromosomal aneuploidies within the 3q26 region in cytological specimens revealing low grade intraepithelial lesions (LSIL). Ikonisys Inc....
BioCentury | Dec 21, 2009
Company News

Enzo, Ikonisys sales and marketing update

...Enzo's Enzo Clinical Lab received exclusive rights to market Ikonisys' oncoFISH cervical cancer diagnostic to physicians...
...York and New Jersey. Financial terms were not disclosed. Enzo Biochem Inc. (NYSE:ENZ), Farmingdale, N.Y. Ikonisys Inc....
BioCentury | Nov 3, 2008
Clinical News

OncoFISH her2 regulatory update

...FDA approved a 510(k) application from Ikonisys for its oncoFISH her2 test to detect HER2 status...
...processed with the PathVysion Her2 DNA Probe Kit from Abbott Laboratories (NYSE:ABT, Abbott Park, Ill.). Ikonisys Inc....
BioCentury | Sep 29, 2008
Company News

Ikonisys sales and marketing update

...is used to assess the risk of progression of low grade dysplasia to cervical cancer. Ikonisys Inc....
BioCentury | Jun 23, 2008
Company News

Ikonisys management update

Ikonisys Inc. , New Haven, Conn. Business: Diagnostic Hired: Louise Mawhinney as SVP and CFO, formerly SVP and CFO at Helicos BioSciences Corp. ; she replaces Paul White, who will remain president WIR Staff Diagnostic...
BioCentury | May 22, 2008
Distillery Therapeutics

This Week in Therapeutics

...effect of the mutation, which is predicted to be involved in the protein N-glycosylation process. Ikonisys Inc....
BioCentury | May 22, 2008
Distillery Therapeutics

This Week in Therapeutics

...of the mutations and how defects in OTase can nevertheless result in normal cellular N-glycosylation. Ikonisys Inc....
BioCentury | Feb 25, 2008
Clinical News

FastFISH fetal update

...in detecting trisomy 21 in circulating fetal cells of pregnant women during the first trimester. Ikonisys Inc....
BioCentury | Oct 18, 2007
Financial News

Ikonisys raises $30 million

...Molecular diagnostics company Ikonisys (New Haven, Conn.) raised $30 million in a series E round. New...
BioCentury | May 12, 2003
Company News

Genaissance management update

...Ben Kaplan as SVP and CFO, formerly SVP of finance and administration and CFO at Ikonisys Inc....
Items per page:
1 - 10 of 12
BioCentury | Feb 15, 2010
Company News

Ikonisys sales and marketing update

...chromosomal aneuploidies within the 3q26 region in cytological specimens revealing low grade intraepithelial lesions (LSIL). Ikonisys Inc....
BioCentury | Dec 21, 2009
Company News

Enzo, Ikonisys sales and marketing update

...Enzo's Enzo Clinical Lab received exclusive rights to market Ikonisys' oncoFISH cervical cancer diagnostic to physicians...
...York and New Jersey. Financial terms were not disclosed. Enzo Biochem Inc. (NYSE:ENZ), Farmingdale, N.Y. Ikonisys Inc....
BioCentury | Nov 3, 2008
Clinical News

OncoFISH her2 regulatory update

...FDA approved a 510(k) application from Ikonisys for its oncoFISH her2 test to detect HER2 status...
...processed with the PathVysion Her2 DNA Probe Kit from Abbott Laboratories (NYSE:ABT, Abbott Park, Ill.). Ikonisys Inc....
BioCentury | Sep 29, 2008
Company News

Ikonisys sales and marketing update

...is used to assess the risk of progression of low grade dysplasia to cervical cancer. Ikonisys Inc....
BioCentury | Jun 23, 2008
Company News

Ikonisys management update

Ikonisys Inc. , New Haven, Conn. Business: Diagnostic Hired: Louise Mawhinney as SVP and CFO, formerly SVP and CFO at Helicos BioSciences Corp. ; she replaces Paul White, who will remain president WIR Staff Diagnostic...
BioCentury | May 22, 2008
Distillery Therapeutics

This Week in Therapeutics

...effect of the mutation, which is predicted to be involved in the protein N-glycosylation process. Ikonisys Inc....
BioCentury | May 22, 2008
Distillery Therapeutics

This Week in Therapeutics

...of the mutations and how defects in OTase can nevertheless result in normal cellular N-glycosylation. Ikonisys Inc....
BioCentury | Feb 25, 2008
Clinical News

FastFISH fetal update

...in detecting trisomy 21 in circulating fetal cells of pregnant women during the first trimester. Ikonisys Inc....
BioCentury | Oct 18, 2007
Financial News

Ikonisys raises $30 million

...Molecular diagnostics company Ikonisys (New Haven, Conn.) raised $30 million in a series E round. New...
BioCentury | May 12, 2003
Company News

Genaissance management update

...Ben Kaplan as SVP and CFO, formerly SVP of finance and administration and CFO at Ikonisys Inc....
Items per page:
1 - 10 of 12